All In MedTech

Device Trial Radar · NCT06011551

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 225 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

225

Planned (sponsor's estimate)

Start

Jan 13, 2025

Primary completion

Dec 31, 2027

Study completion Dec 31, 2028

Sponsor

Lead sponsor
ReGelTec, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 25, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.

Conditions

  • Degenerative Disc Disease (DDD)

Interventions

  • The ReGelTec HYDRAFIL™ SystemDevice

    The ReGelTec HYDRAFIL System is designed to deliver an injectable hydrogel implant (the HYDRAFIL implant) for the treatment of a degenerative lumbar disc.

  • Conservative Care ManagementOther

    Conservative care management (including physical therapy and/or pain medication)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Endpoint of Clinical SuccessTime frame: 12-month

Locations

16 sites in 2 countries. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics

    Birmingham, Alabama · Recruiting

  • Source Healthcare

    Santa Monica, California · Recruiting

  • Boomerang Healthcare (IPM Medical Group)

    Walnut Creek, California · Recruiting

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.